{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvre jaune : Questions médicales les plus fréquentes",
"headline": "Fièvre jaune : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvre jaune"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Fièvres hémorragiques virales",
"url": "https://questionsmedicales.fr/mesh/D006482",
"about": {
"@type": "MedicalCondition",
"name": "Fièvres hémorragiques virales",
"code": {
"@type": "MedicalCode",
"code": "D006482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fièvre jaune",
"alternateName": "Yellow Fever",
"code": {
"@type": "MedicalCode",
"code": "D015004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pedro Augusto Alves",
"url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves",
"affiliation": {
"@type": "Organization",
"name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Erna Geessien Kroon",
"url": "https://questionsmedicales.fr/author/Erna%20Geessien%20Kroon",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Betânia Paiva Drumond",
"url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Anna-Bella Failloux",
"url": "https://questionsmedicales.fr/author/Anna-Bella%20Failloux",
"affiliation": {
"@type": "Organization",
"name": "Institut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France. anna-bella.failloux@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Laurence Cibrelus",
"url": "https://questionsmedicales.fr/author/Laurence%20Cibrelus",
"affiliation": {
"@type": "Organization",
"name": "World Health Organisation, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36097245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00691-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37047951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20075336"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global pen pal education intervention among student pharmacists: A pilot project.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36153244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cptl.2022.09.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39457265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph21101292"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36798046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231157833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fièvres hémorragiques virales",
"item": "https://questionsmedicales.fr/mesh/D006482"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fièvre jaune",
"item": "https://questionsmedicales.fr/mesh/D015004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvre jaune - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvre jaune",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvre jaune",
"description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour confirmer la fièvre jaune ?\nQuels symptômes indiquent une fièvre jaune ?\nLa fièvre jaune peut-elle être confondue avec d'autres maladies ?\nQuel rôle joue l'historique de voyage dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvre jaune",
"description": "Quels sont les premiers symptômes de la fièvre jaune ?\nLa jaunisse est-elle un symptôme de la fièvre jaune ?\nQuels symptômes indiquent une forme sévère de la maladie ?\nLes symptômes de la fièvre jaune évoluent-ils rapidement ?\nPeut-on avoir des symptômes sans être infecté ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvre jaune",
"description": "Comment se protéger contre la fièvre jaune ?\nLa vaccination est-elle efficace contre la fièvre jaune ?\nÀ quel âge peut-on se faire vacciner contre la fièvre jaune ?\nFaut-il un certificat de vaccination pour voyager ?\nLes moustiquaires sont-elles utiles pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvre jaune",
"description": "Quel est le traitement principal pour la fièvre jaune ?\nLes antibiotiques sont-ils efficaces contre la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on prévenir la fièvre jaune par des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvre jaune",
"description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle entraîner la mort ?\nQuels organes peuvent être affectés par la fièvre jaune ?\nLes complications surviennent-elles rapidement ?\nPeut-on récupérer complètement après des complications ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvre jaune",
"description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se faire vacciner avant de partir ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes conditions de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fièvre jaune ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et des tests sanguins pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la fièvre jaune ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont utilisés pour confirmer la présence du virus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une fièvre jaune ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, douleurs musculaires, et jaunisse sont des symptômes clés."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle être confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou l'hépatite virale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique de voyage dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique de voyage dans des zones endémiques est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les premiers symptômes de la fièvre jaune ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les premiers symptômes incluent fièvre, frissons, et douleurs musculaires."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme de la fièvre jaune ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse apparaît souvent dans les cas avancés de fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une forme sévère de la maladie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des douleurs abdominales et une défaillance organique signalent une forme sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes de la fièvre jaune évoluent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent évoluer rapidement, nécessitant une attention médicale urgente."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans être infecté ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes similaires peuvent apparaître sans infection, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre la fièvre jaune ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et évitez les zones à moustiques."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre la fièvre jaune ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est très efficace et recommandée pour les voyageurs dans les zones à risque."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on se faire vacciner contre la fièvre jaune ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est recommandée à partir de 9 mois."
}
},
{
"@type": "Question",
"name": "Faut-il un certificat de vaccination pour voyager ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un certificat de vaccination peut être exigé pour entrer dans certains pays."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles utiles pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires traitées sont efficaces pour réduire les piqûres de moustiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour la fièvre jaune ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la fièvre jaune ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car la fièvre jaune est causée par un virus."
}
},
{
"@type": "Question",
"name": "Comment gérer la déshydratation due à la fièvre jaune ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation par voie intraveineuse est essentielle pour gérer la déshydratation."
}
},
{
"@type": "Question",
"name": "Des soins intensifs sont-ils nécessaires pour les cas graves ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller les organes."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la fièvre jaune par des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention repose principalement sur la vaccination, pas sur des traitements."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre jaune ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels organes peuvent être affectés par la fièvre jaune ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le foie, les reins et le cœur peuvent être gravement affectés par la maladie."
}
},
{
"@type": "Question",
"name": "Les complications surviennent-elles rapidement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir dans les 7 à 10 jours suivant l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on récupérer complètement après des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent récupérer complètement, mais d'autres peuvent avoir des séquelles."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la fièvre jaune ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se faire vacciner avant de partir ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est fortement recommandée pour les voyageurs vers des zones à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de complications graves."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque plus élevé de maladie sévère."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones avec des moustiques augmente le risque de transmission."
}
}
]
}
]
}
Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro...
An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p...
A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple...
This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...
Profound health disparities are widespread among Native Hawaiians, other Pacific Islanders, and Filipinos in Hawai'i. Efforts to reduce and eliminate health disparities are limited by a shortage of in...
Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim...
This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm...
In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...
In developing countries, there is currently no established waste management plan that includes resource recovery from used disposable diapers (DDs) apart from incineration and landfilling. In low-inco...
In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan...
Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and...
The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...
Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab...
During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ...
The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga...
One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...
To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th...
Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,...
A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported....
This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...
We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events....
Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a...
There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions...
This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...
American Indian Alaska Native (AIAN) youth have disproportionately higher rates of commercial tobacco product use compared to other racial and ethnic groups in the U.S. These rates underscore a need f...
The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho...
vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a...
The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche...
vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...